Bibliography
- Nakagawa O , OgawaY, ItohHet al. : Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload.J. Clin. Invest.96, 1280–1287 (1995).
- Hunt PJ , RichardsAM, NichollsMG, YandleTG, DoughtyRN, EspinerEA: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.Clin. Endocrinol. (Oxf.)47, 287–296 (1997).
- Lainchbury JG , NichollsMG, EspinerEA, IkramH, YandleTG, RichardsAM: Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.Clin. Sci. (Lond.)95, 547–555 (1998).
- Schou M , DalsgaardMK, ClemmesenOet al. : Kidneys extract BNP and NT-proBNP in healthy young men.J. Appl. Physiol.99, 1676–1680 (2005).
- Goetze JP , JensenG, MollerS, BendtsenF, RehfeldJF, HenriksenJH: BNP and N-terminal proBNP are both extracted in the normal kidney.Eur. J. Clin. Invest.36, 8–15 (2006).
- Sokoll LJ , BaumH, CollinsonPOet al. : Multicenter analytical performance evaluation of the Elecsys proBNP assay.Clin. Chem. Lab. Med.42, 965–972 (2004).
- Steele IC , McDowellG, MooreAet al. : Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects.Eur. J. Clin. Invest.27, 270–276 (1997).
- Scharhag J , HerrmannM, UrhausenA, HaschkeM, HerrmannW, KindermannW: Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise.Am. Heart J.150, 1128–1134 (2005).
- Ohba H , TakadaH, MushaHet al. : Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.Am. Heart J.141, 751–758 (2001).
- Scharhag J , HerrmannM, WeissingerM, HerrmannW, KindermannW: N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.Clin. Res. Cardiol.96, 218–226 (2007).
- Foote RS , PearlmanJD, SiegelAH, YeoKT: Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.J. Am. Coll. Cardiol.44, 1980–1987 (2004).
- Yeo KT , LeeHK, WongKC, FooteRS: Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia?J. Card. Fail.11, S59–S64 (2005).
- Sabatine MS , MorrowDA, de Lemos JA et al.: Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J. Am. Coll. Cardiol.44, 1988–1995 (2004).
- Weber M , DillT, ArnoldRet al. : N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.Am. Heart J.148, 612–620 (2004).
- Mueller T , GegenhuberA, DieplingerB, PoelzW, HaltmayerM: Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.Clin. Chem. Lab. Med.42, 942–944 (2004).
- Nowatzke WL , ColeTG: Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze-thaw cycles.Clin. Chem.49, 1560–1562 (2003).
- Vanderheyden M , Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L: Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Clin. Biochem.39, 640–645 (2006).
- Chien TI , ChenHH, KaoJT: Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.Clin. Chim. Acta369, 95–99 (2006).
- Rawlins ML , OwenWE, RobertsWL: Performance characteristics of four automated natriuretic peptide assays.Am. J. Clin. Pathol.123, 439–445 (2005).
- Yeo KT , WuAH, AppleFSet al. : Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.Clin. Chim. Acta338, 107–115 (2003).
- McDonagh TA , HolmerS, RaymondI, LuchnerA, HildebrantP, DargieHJ: NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.Eur. J. Heart Fail.6, 269–273 (2004).
- McDonagh TA , RobbSD, MurdochDRet al. : Biochemical detection of left-ventricular systolic dysfunction.Lancet351, 9–13 (1998).
- Lubien E , DeMariaA, KrishnaswamyPet al. : Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.Circulation105, 595–601 (2002).
- Tschope C , KasnerM, WestermannD, GaubR, PollerWC, SchultheissHP: The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.Eur. Heart J.26, 2277–2284 (2005).
- Kasner M , WestermannD, SteendijkPet al. : Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study.Circulation116, 637–647 (2007).
- Silver MA , MaiselA, YancyCWet al. : BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Congest. Heart Fail.10, 1–30 (2004).
- Maisel AS : The diagnosis of acute congestive heart failure: role of BNP measurements.Heart Fail. Rev.8, 327–334 (2003).
- Costello-Boerrigter LC , BoerrigterG, RedfieldMMet al. : Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.J. Am. Coll. Cardiol.47, 345–353 (2006).
- Zaphiriou A , RobbS, Murray-ThomasTet al. : The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.Eur. J. Heart Fail.7, 537–541 (2005).
- Rutten FH , CramerMJ, ZuithoffNPet al. : Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease.Eur. J. Heart Fail.9, 651–659 (2007).
- Januzzi JL et al. Jr, Camargo CA, Anwaruddin S : The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol.95, 948–954 (2005).
- Januzzi JL et al. , van Kimmenade R, Lainchbury J : NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur. Heart J.27, 330–337 (2006).
- Kazanegra R , ChengV, GarciaAet al. : A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.J. Card. Fail.7, 21–29 (2001).
- Knebel F , SchimkeI, PlietKet al. : NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation.J. Card. Fail.11, S38–S41 (2005).
- Gegenhuber A , MuellerT, FirlingerF, LenzK, PoelzW, HaltmayerM: Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure.Clin. Chem.50, 454–456 (2004).
- Mueller T , GegenhuberA, PoelzW, HaltmayerM: Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.Clin. Chim. Acta341, 41–48 (2004).
- Mueller T , GegenhuberA, PoelzW, HaltmayerM: Biochemical diagnosis of impaired left ventricular ejection fraction – comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).Clin. Chem. Lab. Med.42, 159–163 (2004).
- Emdin M , PassinoC, PronteraCet al. : Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.Clin. Chem.53, 1289–1297 (2007).
- de Lemos JA , McGuireDK, KheraAet al. : Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.Am. Heart J.157, 746–753 e2 (2009).
- Clerico A , FontanaM, ZywL, PassinoC, EmdinM: Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.Clin. Chem.53, 813–822 (2007).
- Tsutamoto T , WadaA, MaedaKet al. : Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.Circulation96, 509–516 (1997).
- Yu CM , SandersonJE: Plasma brain natriuretic peptide – an independent predictor of cardiovascular mortality in acute heart failure.Eur. J. Heart Fail.1, 59–65 (1999).
- Maeda K , TsutamotoT, WadaAet al. : High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.J. Am. Coll. Cardiol.36, 1587–1593 (2000).
- Koglin J , PehlivanliS, SchwaiblmairM, VogeserM, CremerP, vonScheidtW: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.J. Am. Coll. Cardiol.38, 1934–1941 (2001).
- Berger R , HuelsmanM, StreckerKet al. : B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.Circulation105, 2392–2397 (2002).
- Gardner RS , OzalpF, MurdayAJ, RobbSD, McDonaghTA: N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure.Eur. Heart J.24, 1735–1743 (2003).
- Anand IS , FisherLD, ChiangYTet al. : Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).Circulation107, 1278–1283 (2003).
- Masson S , LatiniR, AnandISet al. : Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.Clin. Chem.52, 1528–1538 (2006).
- de Lemos JA , MorrowDA, BentleyJHet al. : The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.N. Engl. J. Med.345, 1014–1021 (2001).
- Sabatine MS , MorrowDA, de Lemos JA et al.: Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation105, 1760–1763 (2002).
- James SK , LindahlB, SiegbahnAet al. : N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.Circulation108, 275–281 (2003).
- Morrow DA , de Lemos JA, Sabatine MS et al.: Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J. Am. Coll. Cardiol.41, 1264–1272 (2003).
- Omland T , AakvaagA, BonarjeeVVet al. : Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.Circulation93, 1963–1969 (1996).
- Richards AM , NichollsMG, YandleTGet al. : Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.Circulation97, 1921–1929 (1998).
- Richards AM , NichollsMG, EspinerEAet al. : B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.Circulation107, 2786–2792 (2003).
- Suzuki S , YoshimuraM, NakayamaMet al. : Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.Circulation110, 1387–1391 (2004).
- Richards M , NichollsMG, EspinerEAet al. : Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.J. Am. Coll. Cardiol.47, 52–60 (2006).
- ten Wolde M , Tulevski,II, MulderJWet al. : Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism.Circulation107, 2082–2084 (2003).
- Kucher N , PrintzenG, GoldhaberSZ: Prognostic role of brain natriuretic peptide in acute pulmonary embolism.Circulation107, 2545–2547 (2003).
- Hutfless R , KazanegraR, MadaniMet al. : Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.J. Am. Coll. Cardiol.43, 1873–1879 (2004).
- Yeh HM , LauHP, LinJM, SunWZ, WangMJ, LaiLP: Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery.Br. J. Surg.92, 1041–1045 (2005).
- Hildebrandt P , BoesenM, OlsenM, WachtellK, GroenningB: N-terminal pro brain natriuretic peptide in arterial hypertension – a marker for left ventricular dimensions and prognosis.Eur. J. Heart Fail.6, 313–317 (2004).
- Blankenberg S , McQueenMJ, SmiejaMet al. : Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study.Circulation114, 201–208 (2006).
- Wang TJ , LarsonMG, LevyDet al. : Plasma natriuretic peptide levels and the risk of cardiovascular events and death.N. Engl. J. Med.350, 655–663 (2004).
- McKie PM , RodehefferRJ, CataliottiAet al. : Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.Hypertension47, 874–880 (2006).
- Gegenhuber A , MuellerT, DieplingerB, PoelzW, PacherR, HaltmayerM: B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.Clin. Chim. Acta370, 174–179 (2006).
- Wang TJ , LarsonMG, LevyDet al. : Impact of obesity on plasma natriuretic peptide levels.Circulation109, 594–600 (2004).
- Mehra MR , UberPA, ParkMHet al. : Obesity and suppressed B-type natriuretic peptide levels in heart failure.J. Am. Coll. Cardiol.43, 1590–1595 (2004).
- Bionda C , BergerotC, ArdailD, Rodriguez-LafrasseC, RoussonR: Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.Ann Clin Lab Sci36, 299–306 (2006).
- Muscari A , BerzigottiA, BianchiGet al. : Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis.Eur. J. Heart Fail.8, 468–476 (2006).
- Wang TJ , LarsonMG, LevyDet al. : Heritability and genetic linkage of plasma natriuretic peptide levels.Circulation108, 13–16 (2003).
- Newton-Cheh C , LarsonMG, VasanRSet al. : Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.Nat. Genet.41, 348–353 (2009).
- Redfield MM , RodehefferRJ, JacobsenSJ, MahoneyDW, BaileyKR, BurnettJC Jr: Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol.40, 976–982 (2002).
- Luchner A , BurnettJCet al. Jr, Jougasaki M : Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J. Hypertens.18, 1121–1128 (2000).
- Latini R , MassonS, AnandIet al. : Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).Circulation106, 2454–2458 (2002).
- Luchner A , BurnettJC Jr, Jougasaki M, Hense HW, Riegger GA, Schunkert H: Augmentation of the cardiac natriuretic peptides by β-receptor antagonism: evidence from a population-based study. J. Am. Coll. Cardiol.32, 1839–1844 (1998).
- Cataliotti A , MalatinoLS, JougasakiMet al. : Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.Mayo Clin. Proc.76, 1111–1119 (2001).
- Luchner A , HengstenbergC, LowelHet al. : N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.Hypertension39, 99–104 (2002).
- McCullough PA , KuncheriaJ, MathurVS: Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.Rev. Cardiovasc. Med.5, 16–25 (2004).
- Luchner A , HengstenbergC, LowelH, RieggerGA, SchunkertH, HolmerS: Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.Hypertension46, 118–123 (2005).
- Vickery S , PriceCP, JohnRIet al. : B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.Am. J. Kidney Dis.46, 610–620 (2005).
- Chenevier-Gobeaux C , ClaessensYE, VoyerS, DesmoulinsD, EkindjianOG: Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).Clin. Chim. Acta361, 167–175 (2005).
- DeFilippi CR , FinkJC, NassCM, ChenH, ChristensonR: N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.Am. J. Kidney Dis.46, 35–44 (2005).
- Forfia PR , WatkinsSP, RameJE, StewartKJ, ShapiroEP: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.J. Am. Coll. Cardiol.45, 1667–1671 (2005).
- Tsutamoto T , WadaA, SakaiHet al. : Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.J. Am. Coll. Cardiol.47, 582–586 (2006).
- Anwaruddin S , Lloyd-JonesDM, BaggishAet al. : Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.J. Am. Coll. Cardiol.47, 91–97 (2006).
- Vanderheyden M , BartunekJ, GoethalsM: Brain and other natriuretic peptides: molecular aspects.Eur. J. Heart Fail.6, 261–268 (2004).
- Ozaki J , ShimizuH, HashimotoY, ItohH, NakaoK, InuiK: Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.Eur. J. Pharmacol.370, 307–312 (1999).
- Wieczorek SJ , WuAH, ChristensonRet al. : A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.Am. Heart J.144, 834–839 (2002).
- Wu AH , PackerM, SmithAet al. : Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.Clin. Chem.50, 867–873 (2004).
- Mueller T , GegenhuberA, PoelzW, HaltmayerM: Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay.Clin. Chem.50, 1104–1106 (2004).
- Sanz MP , BorqueL, RusA, VicenteB, RamirezY, LasaL: Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.J. Clin. Lab. Anal.20, 227–232 (2006).
- Mikkelsen KV , BieP, MollerJE, RydeH, VidebaekL, HaghfeltT: Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.Scand. J. Clin. Lab. Invest.65, 633–647 (2005).
- Mueller T , GegenhuberA, PoelzW, HaltmayerM: Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.Heart91, 606–612 (2005).
- Ray P , ArthaudM, BirolleauSet al. : Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.J. Am. Geriatr. Soc.53, 643–648 (2005).
- Pfister R , ScholzM, WielckensK, ErdmannE, SchneiderCA: Use of NT-proBNP in routine testing and comparison to BNP.Eur. J. Heart Fail.6, 289–293 (2004).
- Lainchbury JG , CampbellE, FramptonCM, YandleTG, NichollsMG, RichardsAM: Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.J. Am. Coll. Cardiol.42, 728–735 (2003).